CD274 and cancer: Additionally, cancer cells impede CTL-mediated toxicity by releasing immunosuppressive factors, such as IL-10, TGF-β, programmed death ligand 1 (PD-L1), and prostaglandin E2 (PGE2), which further reduce immunogenicity [59,62,69].